Cormorant Asset Management, LP Closed Holding Positions

Cormorant Asset Management, LP

  • $1.43 Billion
  • Q3 2024
Stock Closed Quarter Shares Sold Price Range Trade History
IWM
Ishares Russell 2000 ETF

ETFs
Q3 2021 Filed on Nov 15, 2021
1,000,000
$211.73 - $231.39 $212M - $231M
CRDF
Cardiff Oncology, Inc.

Healthcare
Q3 2021 Filed on Nov 15, 2021
95,720
$5.01 - $7.58 $480K - $726K
ALLK
Allakos Inc.

Healthcare
Q2 2021 Filed on Aug 16, 2021
25,000
$85.37 - $114.1 $2.13M - $2.85M
FHTX
Foghorn Therapeutics Inc.

Healthcare
Q2 2021 Filed on Aug 16, 2021
1,000,000
$9.32 - $13.26 $9.32M - $13.3M
REPL
Replimune Group, Inc.

Healthcare
Q2 2021 Filed on Aug 16, 2021
125,000
$28.5 - $39.37 $3.56M - $4.92M
BNTX
Bio N Tech Se

Healthcare
Q2 2021 Filed on Aug 16, 2021
100,000
$113.32 - $241.49 $11.3M - $24.1M
Bcls Acquisition Corp
Q2 2021 Filed on Aug 16, 2021
500,000
N/A
XBI
Spdr Ser Tr Spdr S&P Biotech E

ETFs
Q2 2021 Filed on Aug 16, 2021
1,000,000
$122.48 - $139.69 $122M - $140M
ARGX
Argenx Se

Healthcare
Q2 2021 Filed on Aug 16, 2021
30,000
$257.11 - $319.92 $7.71M - $9.6M
ALBO
Albireo Pharma, Inc.

Healthcare
Q2 2021 Filed on Aug 16, 2021
500,000
$28.9 - $36.87 $14.5M - $18.4M
NTLA
Intellia Therapeutics, Inc.

Healthcare
Q2 2021 Filed on Aug 16, 2021
300,000
$60.88 - $161.91 $18.3M - $48.6M
SPY
Spdr S&P 500 ETF Trust

ETFs
Q2 2021 Filed on Aug 16, 2021
1,000,000
$400.61 - $428.06 $401M - $428M
FDMT
4 D Molecular Therapeutics, Inc.

Healthcare
Q2 2021 Filed on Aug 16, 2021
200,000
$22.2 - $42.29 $4.44M - $8.46M
Vesper Healthcare Acqstn Cor
Q2 2021 Filed on Aug 16, 2021
400,000
N/A
GRCL
Gracell Biotechnologies Inc.

Healthcare
Q2 2021 Filed on Aug 16, 2021
125,000
$9.75 - $18.42 $1.22M - $2.3M
KALV
Kal Vista Pharmaceuticals, Inc.

Healthcare
Q2 2021 Filed on Aug 16, 2021
750,000
$23.12 - $29.91 $17.3M - $22.4M
NUVB
Nuvation Bio Inc.

Healthcare
Q2 2021 Filed on Aug 16, 2021
234,445
$9.22 - $14.48 $2.16M - $3.39M
NKTR
Nektar Therapeutics

Healthcare
Q2 2021 Filed on Aug 16, 2021
20,000
$16.52 - $20.4 $330K - $408K
GMTX
Gemini Therapeutics, Inc.

Healthcare
Q2 2021 Filed on Aug 16, 2021
475,000
$6.32 - $14.02 $3M - $6.66M
FATE
Fate Therapeutics Inc

Healthcare
Q2 2021 Filed on Aug 16, 2021
10,000
$67.25 - $92.52 $673K - $925K
Kadmon Hldgs Inc
Q2 2021 Filed on Aug 16, 2021
750,000
N/A
TARA
Protara Therapeutics, Inc.

Healthcare
Q2 2021 Filed on Aug 16, 2021
350,000
$8.68 - $16.99 $3.04M - $5.95M
Arena Pharmaceuticals Inc
Q2 2021 Filed on Aug 16, 2021
20,000
N/A
Therapeutics Acquisition Cor
Q2 2021 Filed on Aug 16, 2021
500,000
N/A
KNSA
Kiniksa Pharmaceuticals, Ltd.

Healthcare
Q2 2021 Filed on Aug 16, 2021
130,000
$13.22 - $19.09 $1.72M - $2.48M
NVAX
Novavax Inc

Healthcare
Q2 2021 Filed on Aug 16, 2021
250,000
$121.0 - $257.67 $30.3M - $64.4M
Fs Dev Corp
Q1 2021 Filed on May 17, 2021
500,000
N/A
QQQ
Invesco Qqq Trust, Series 1

ETFs
Q1 2021 Filed on May 17, 2021
750,000
$299.94 - $336.45 $225M - $252M
Miragen Therapeutics Inc
Q1 2021 Filed on May 17, 2021
93,126
N/A
Panacea Acquisition Corp
Q1 2021 Filed on May 17, 2021
250,000
N/A
Novus Therapeutics Inc
Q1 2021 Filed on May 17, 2021
1,415,500
N/A
OTIC
Otonomy, Inc.

Healthcare
Q1 2021 Filed on May 17, 2021
2,600,000
$2.49 - $6.23 $6.47M - $16.2M
KURA
Kura Oncology, Inc.

Healthcare
Q1 2021 Filed on May 17, 2021
650,000
$24.75 - $39.14 $16.1M - $25.4M
CRSP
Crispr Therapeutics Ag

Healthcare
Q1 2021 Filed on May 17, 2021
200,000
$110.72 - $210.04 $22.1M - $42M
AVRO
Avrobio, Inc.

Healthcare
Q1 2021 Filed on May 17, 2021
244,032
$10.54 - $19.3 $2.57M - $4.71M
Viela Bio Inc
Q1 2021 Filed on May 17, 2021
1,429,200
N/A
GLPG
Galapagos Nv

Healthcare
Q4 2020 Filed on Feb 16, 2021
130,000
$96.85 - $148.25 $12.6M - $19.3M
AMRN
Amarin Corp Plcuk

Healthcare
Q4 2020 Filed on Feb 16, 2021
300,000
$4.04 - $5.31 $1.21M - $1.59M
Trillium Therapeutics Inc
Q4 2020 Filed on Feb 16, 2021
2,500,000
N/A
ARCT
Arcturus Therapeutics Holdings Inc.

Healthcare
Q4 2020 Filed on Feb 16, 2021
700,000
$34.61 - $123.66 $24.2M - $86.6M
Myokardia Inc
Q4 2020 Filed on Feb 16, 2021
450,000
N/A
FIXX
Homology Medicines, Inc.

Healthcare
Q4 2020 Filed on Feb 16, 2021
470,897
$8.92 - $13.29 $4.2M - $6.26M
Eidos Therapeutics Inc
Q4 2020 Filed on Feb 16, 2021
993,185
N/A
Principia Biopharma Inc
Q3 2020 Filed on Nov 16, 2020
1,590,493
N/A
STSA
Satsuma Pharmaceuticals, Inc.

Healthcare
Q3 2020 Filed on Nov 16, 2020
798,905
$3.85 - $28.47 $3.08M - $22.7M
BNR
Burning Rock Biotech LTD

Healthcare
Q3 2020 Filed on Nov 16, 2020
250,000
$19.07 - $29.61 $4.77M - $7.4M
Arya Sciences Acquisition CO
Q3 2020 Filed on Nov 16, 2020
400,000
N/A
NXTC
Next Cure, Inc.

Healthcare
Q3 2020 Filed on Nov 16, 2020
693,971
$8.15 - $21.17 $5.66M - $14.7M
NBIX
Neurocrine Biosciences Inc

Healthcare
Q2 2020 Filed on Aug 14, 2020
25,000
$85.09 - $130.36 $2.13M - $3.26M
Track This Portfolio

Track Cormorant Asset Management, LP Portfolio

Follow Cormorant Asset Management, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cormorant Asset Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Cormorant Asset Management, LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email